Colorectal cancer deaths attributable to nonuse of screening in the United States

Purpose: Screening is a major contributor to colorectal cancer (CRC) mortality reductions in the United States but is underused. We estimated the fraction of CRC deaths attributable to nonuse of screening to demonstrate the potential benefits from targeted interventions. Methods: The established mic...

Full description

Bibliographic Details
Main Authors: Meester, R., Doubeni, C., Lansdorp_Vogelaar, Iris, Goede, S., Levin, T., Quinn, V., van Ballegooijen, M., Corley, D., Zauber, A.
Format: Journal Article
Published: Elsevier 2015
Online Access:http://hdl.handle.net/20.500.11937/49795
_version_ 1848758316426067968
author Meester, R.
Doubeni, C.
Lansdorp_Vogelaar, Iris
Goede, S.
Levin, T.
Quinn, V.
van Ballegooijen, M.
Corley, D.
Zauber, A.
author_facet Meester, R.
Doubeni, C.
Lansdorp_Vogelaar, Iris
Goede, S.
Levin, T.
Quinn, V.
van Ballegooijen, M.
Corley, D.
Zauber, A.
author_sort Meester, R.
building Curtin Institutional Repository
collection Online Access
description Purpose: Screening is a major contributor to colorectal cancer (CRC) mortality reductions in the United States but is underused. We estimated the fraction of CRC deaths attributable to nonuse of screening to demonstrate the potential benefits from targeted interventions. Methods: The established microsimulation screening analysis colon model was used to estimate the population attributable fraction (PAF) in people aged =50years. The model incorporates long-term patterns and effects of screening by age and type of screening test. PAF for 2010 was estimated using currently available data on screening uptake. PAF was also projected assuming constant future screening rates to incorporate lagged effects from past increases in screening uptake. We also computed PAF using Levin's formula to gauge how this simpler approach differs from the model-based approach. Results: There were an estimated 51,500 CRC deaths in 2010, about 63% (N ~ 32,200) of which were attributable to nonscreening. The PAF decreases slightly to 58% in 2020. Levin's approach yielded a considerably more conservative PAF of 46% (N ~ 23,600) for2010. Conclusions: Most of the current United States CRC deaths are attributable to nonscreening. This underscores the potential benefits of increasing screening uptake in the population. Traditional methods of estimating PAF underestimated screening effects compared with model-based approaches.
first_indexed 2025-11-14T09:42:03Z
format Journal Article
id curtin-20.500.11937-49795
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T09:42:03Z
publishDate 2015
publisher Elsevier
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-497952018-03-29T09:07:46Z Colorectal cancer deaths attributable to nonuse of screening in the United States Meester, R. Doubeni, C. Lansdorp_Vogelaar, Iris Goede, S. Levin, T. Quinn, V. van Ballegooijen, M. Corley, D. Zauber, A. Purpose: Screening is a major contributor to colorectal cancer (CRC) mortality reductions in the United States but is underused. We estimated the fraction of CRC deaths attributable to nonuse of screening to demonstrate the potential benefits from targeted interventions. Methods: The established microsimulation screening analysis colon model was used to estimate the population attributable fraction (PAF) in people aged =50years. The model incorporates long-term patterns and effects of screening by age and type of screening test. PAF for 2010 was estimated using currently available data on screening uptake. PAF was also projected assuming constant future screening rates to incorporate lagged effects from past increases in screening uptake. We also computed PAF using Levin's formula to gauge how this simpler approach differs from the model-based approach. Results: There were an estimated 51,500 CRC deaths in 2010, about 63% (N ~ 32,200) of which were attributable to nonscreening. The PAF decreases slightly to 58% in 2020. Levin's approach yielded a considerably more conservative PAF of 46% (N ~ 23,600) for2010. Conclusions: Most of the current United States CRC deaths are attributable to nonscreening. This underscores the potential benefits of increasing screening uptake in the population. Traditional methods of estimating PAF underestimated screening effects compared with model-based approaches. 2015 Journal Article http://hdl.handle.net/20.500.11937/49795 10.1016/j.annepidem.2014.11.011 Elsevier restricted
spellingShingle Meester, R.
Doubeni, C.
Lansdorp_Vogelaar, Iris
Goede, S.
Levin, T.
Quinn, V.
van Ballegooijen, M.
Corley, D.
Zauber, A.
Colorectal cancer deaths attributable to nonuse of screening in the United States
title Colorectal cancer deaths attributable to nonuse of screening in the United States
title_full Colorectal cancer deaths attributable to nonuse of screening in the United States
title_fullStr Colorectal cancer deaths attributable to nonuse of screening in the United States
title_full_unstemmed Colorectal cancer deaths attributable to nonuse of screening in the United States
title_short Colorectal cancer deaths attributable to nonuse of screening in the United States
title_sort colorectal cancer deaths attributable to nonuse of screening in the united states
url http://hdl.handle.net/20.500.11937/49795